Literature DB >> 22695850

Altered expression of sialidases in human cancer.

Taeko Miyagi1, K Takahashi, S Moriya, K Hata, K Yamamoto, T Wada, K Yamaguchi, K Shiozaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22695850     DOI： 10.1007/978-1-4614-3381-1_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies.

Authors:  Milo Frattini; Francesca Molinari; Samantha Epistolio
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  The role of complement in tumor growth.

Authors:  Ruben Pio; Leticia Corrales; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.

Authors:  Matilde Forcella; Monica Oldani; Samantha Epistolio; Stefania Freguia; Eugenio Monti; Paola Fusi; Milo Frattini
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 4.  Sialylation of N-glycans: mechanism, cellular compartmentalization and function.

Authors:  Gaurang P Bhide; Karen J Colley
Journal:  Histochem Cell Biol       Date:  2016-12-14       Impact factor: 4.304

5.  Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines.

Authors:  Federica Bovio; Samantha Epistolio; Alessandra Mozzi; Eugenio Monti; Paola Fusi; Matilde Forcella; Milo Frattini
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 6.  Complement inhibition in cancer therapy.

Authors:  Ruben Pio; Daniel Ajona; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-24       Impact factor: 10.671

7.  Visualization of sialidase activity in Mammalian tissues and cancer detection with a novel fluorescent sialidase substrate.

Authors:  Akira Minami; Tadamune Otsubo; Daisuke Ieno; Kiyoshi Ikeda; Hiroaki Kanazawa; Kosuke Shimizu; Ko Ohata; Tsunehiro Yokochi; Yuuki Horii; Hokuto Fukumoto; Risa Taguchi; Tadanobu Takahashi; Naoto Oku; Takashi Suzuki
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

8.  Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.

Authors:  Sasiprapa Wattanavises; Atit Silsirivanit; Kanlayanee Sawanyawisuth; Ubon Cha'on; Sakda Waraasawapati; Waraporn Saentaweesuk; Sukanya Luang; Chalongchai Chalermwat; Chaisiri Wongkham; Sopit Wongkham
Journal:  Medicina (Kaunas)       Date:  2019-11-28       Impact factor: 2.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.